EP0387348A1 - Composites de polymere-organobismuth homogenes et radio-opaques - Google Patents
Composites de polymere-organobismuth homogenes et radio-opaquesInfo
- Publication number
- EP0387348A1 EP0387348A1 EP89911685A EP89911685A EP0387348A1 EP 0387348 A1 EP0387348 A1 EP 0387348A1 EP 89911685 A EP89911685 A EP 89911685A EP 89911685 A EP89911685 A EP 89911685A EP 0387348 A1 EP0387348 A1 EP 0387348A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- substituted phenyls
- polymer
- alkene
- ester
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000002131 composite material Substances 0.000 title abstract description 42
- 229920000642 polymer Polymers 0.000 claims abstract description 75
- 229910001385 heavy metal Inorganic materials 0.000 claims abstract description 45
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 36
- 239000000203 mixture Substances 0.000 claims abstract description 30
- 238000000034 method Methods 0.000 claims abstract description 24
- 150000001875 compounds Chemical class 0.000 claims abstract description 16
- 150000001336 alkenes Chemical group 0.000 claims abstract description 13
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 12
- 150000002148 esters Chemical group 0.000 claims abstract description 12
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 12
- 150000002367 halogens Chemical class 0.000 claims abstract description 10
- 125000003118 aryl group Chemical group 0.000 claims abstract description 6
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims abstract description 6
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 claims abstract description 6
- ZHXAZZQXWJJBHA-UHFFFAOYSA-N triphenylbismuthane Chemical compound C1=CC=CC=C1[Bi](C=1C=CC=CC=1)C1=CC=CC=C1 ZHXAZZQXWJJBHA-UHFFFAOYSA-N 0.000 claims description 25
- 239000000178 monomer Substances 0.000 claims description 21
- 150000002902 organometallic compounds Chemical class 0.000 claims description 20
- 238000006116 polymerization reaction Methods 0.000 claims description 14
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims description 13
- 229910052797 bismuth Inorganic materials 0.000 claims description 13
- 239000002904 solvent Substances 0.000 claims description 12
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 claims description 8
- 238000000807 solvent casting Methods 0.000 claims description 5
- 239000003431 cross linking reagent Substances 0.000 claims description 3
- 229920005862 polyol Polymers 0.000 claims description 3
- 150000003077 polyols Chemical class 0.000 claims description 3
- 238000010128 melt processing Methods 0.000 claims description 2
- 239000002952 polymeric resin Substances 0.000 claims description 2
- 230000000379 polymerizing effect Effects 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims description 2
- 229920003002 synthetic resin Polymers 0.000 claims description 2
- 210000000056 organ Anatomy 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 24
- 229920005989 resin Polymers 0.000 abstract description 12
- 239000011347 resin Substances 0.000 abstract description 12
- 150000002894 organic compounds Chemical class 0.000 abstract description 8
- 230000005855 radiation Effects 0.000 abstract description 7
- 229920000728 polyester Polymers 0.000 abstract description 5
- 239000012633 leachable Substances 0.000 abstract description 4
- 238000002360 preparation method Methods 0.000 abstract description 4
- 239000004744 fabric Substances 0.000 abstract description 3
- 125000005843 halogen group Chemical group 0.000 abstract description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 230000000704 physical effect Effects 0.000 abstract 1
- -1 for example Chemical class 0.000 description 20
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 12
- 239000008188 pellet Substances 0.000 description 12
- 150000003839 salts Chemical class 0.000 description 9
- 239000003999 initiator Substances 0.000 description 8
- 229920003023 plastic Polymers 0.000 description 8
- 239000004033 plastic Substances 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 7
- 239000004743 Polypropylene Substances 0.000 description 6
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 6
- 229920001155 polypropylene Polymers 0.000 description 6
- 229910052782 aluminium Inorganic materials 0.000 description 5
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 5
- 235000019400 benzoyl peroxide Nutrition 0.000 description 5
- 229920001577 copolymer Polymers 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 239000007943 implant Substances 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 description 4
- 239000004342 Benzoyl peroxide Substances 0.000 description 4
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- 229960003328 benzoyl peroxide Drugs 0.000 description 4
- 235000010290 biphenyl Nutrition 0.000 description 4
- 239000004305 biphenyl Substances 0.000 description 4
- 238000004132 cross linking Methods 0.000 description 4
- 230000002209 hydrophobic effect Effects 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 4
- 239000004800 polyvinyl chloride Substances 0.000 description 4
- 229920000915 polyvinyl chloride Polymers 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 239000003899 bactericide agent Substances 0.000 description 3
- 125000006267 biphenyl group Chemical group 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000000855 fungicidal effect Effects 0.000 description 3
- 239000000417 fungicide Substances 0.000 description 3
- 210000003709 heart valve Anatomy 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- 238000002386 leaching Methods 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 150000002736 metal compounds Chemical class 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 3
- 239000004926 polymethyl methacrylate Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
- LTHJXDSHSVNJKG-UHFFFAOYSA-N 2-[2-[2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOCCOCCOC(=O)C(C)=C LTHJXDSHSVNJKG-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000725101 Clea Species 0.000 description 2
- AMFGWXWBFGVCKG-UHFFFAOYSA-N Panavia opaque Chemical compound C1=CC(OCC(O)COC(=O)C(=C)C)=CC=C1C(C)(C)C1=CC=C(OCC(O)COC(=O)C(C)=C)C=C1 AMFGWXWBFGVCKG-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 238000000149 argon plasma sintering Methods 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 229910052788 barium Inorganic materials 0.000 description 2
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000002639 bone cement Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000002872 contrast media Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000009477 glass transition Effects 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol Substances OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- GYVGXEWAOAAJEU-UHFFFAOYSA-N n,n,4-trimethylaniline Chemical compound CN(C)C1=CC=C(C)C=C1 GYVGXEWAOAAJEU-UHFFFAOYSA-N 0.000 description 2
- 125000002524 organometallic group Chemical group 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 101100514821 Caenorhabditis elegans dsc-4 gene Proteins 0.000 description 1
- 239000002879 Lewis base Substances 0.000 description 1
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 238000012644 addition polymerization Methods 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001621 bismuth Chemical class 0.000 description 1
- JHXKRIRFYBPWGE-UHFFFAOYSA-K bismuth chloride Chemical compound Cl[Bi](Cl)Cl JHXKRIRFYBPWGE-UHFFFAOYSA-K 0.000 description 1
- 229960001482 bismuth subnitrate Drugs 0.000 description 1
- TXKAQZRUJUNDHI-UHFFFAOYSA-K bismuth tribromide Chemical compound Br[Bi](Br)Br TXKAQZRUJUNDHI-UHFFFAOYSA-K 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000012662 bulk polymerization Methods 0.000 description 1
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229920001795 coordination polymer Polymers 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 239000004851 dental resin Substances 0.000 description 1
- 210000004268 dentin Anatomy 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- 238000000113 differential scanning calorimetry Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000007720 emulsion polymerization reaction Methods 0.000 description 1
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000004394 hip joint Anatomy 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229910052747 lanthanoid Inorganic materials 0.000 description 1
- 150000002602 lanthanoids Chemical class 0.000 description 1
- 150000007527 lewis bases Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229920005588 metal-containing polymer Polymers 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- GMIRUNZIZZVQCK-UHFFFAOYSA-N methyl 2-methylprop-2-enoate;triphenylbismuthane Chemical compound COC(=O)C(C)=C.C1=CC=CC=C1[Bi](C=1C=CC=CC=1)C1=CC=CC=C1 GMIRUNZIZZVQCK-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100001223 noncarcinogenic Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000004789 organ system Anatomy 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- QGWDKKHSDXWPET-UHFFFAOYSA-E pentabismuth;oxygen(2-);nonahydroxide;tetranitrate Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[O-2].[Bi+3].[Bi+3].[Bi+3].[Bi+3].[Bi+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O QGWDKKHSDXWPET-UHFFFAOYSA-E 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000006069 physical mixture Substances 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 238000012643 polycondensation polymerization Methods 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000002601 radiography Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 239000011342 resin composition Substances 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 239000002631 root canal filling material Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000935 solvent evaporation Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010557 suspension polymerization reaction Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 150000004072 triols Chemical class 0.000 description 1
- DNYWZCXLKNTFFI-UHFFFAOYSA-N uranium Chemical compound [U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U][U] DNYWZCXLKNTFFI-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F2/00—Processes of polymerisation
- C08F2/44—Polymerisation in the presence of compounding ingredients, e.g. plasticisers, dyestuffs, fillers
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21F—PROTECTION AGAINST X-RADIATION, GAMMA RADIATION, CORPUSCULAR RADIATION OR PARTICLE BOMBARDMENT; TREATING RADIOACTIVELY CONTAMINATED MATERIAL; DECONTAMINATION ARRANGEMENTS THEREFOR
- G21F1/00—Shielding characterised by the composition of the materials
- G21F1/02—Selection of uniform shielding materials
- G21F1/10—Organic substances; Dispersions in organic carriers
- G21F1/103—Dispersions in organic carriers
- G21F1/106—Dispersions in organic carriers metallic dispersions
Definitions
- the present invention relates to new and useful
- radiopaque polymers containing heavy metal salts have not bee totally satisfactory.
- One type of known heavy metal-containing radiopaque materials are radiopaque glass containing embedded heavy metals. In these materials, the metal is not molecularly bou to the polymer matrix and, therefore, has a tendency to weake the composite.
- glass filler based resins lack homogeneity a further weakening of regions in the matrix results. Those regions of a composite having little or no glass are radiolucent.
- a light scattering effec is produced by radiopaque glasses which alters optical properties and renders them optically opaque. 1 Polymers with added inorganic heavy metal salts in an
- Such composites require that the complexing polymer contain at least one monomer which is capable of
- a further objective of this invention is to provide
- radiopacifying or x-ray ⁇ contrast additive may also act as a bactericide, fungicide,
- the heavy metal containing organic compound has
- R 1; R and R 3 may be the same or
- Heavy metals useful in this invention have atomic 1 numbers of 50 to 92, an more preferrably, atomic numbers of 7
- the present invention are relatively non-polar and are thus
- 27 bismuth include bactericide, fungicide, antioxidant and
- the present invention provides
- radiopaque materials which comprise a heavy metal containin
- a heavy meta 2 containing organic compound such as an organobismuth compo
- this invention provides radiopa
- Rl, R , R3 substituents is a polymerizable group, such as,
- the heavy metal radio-pacifying agent is non-leachable.
- the polymer composite may be formed from any monome or mixture of monomers into which the selected organometallic compound can be solubilized. It may also be formed by castin a homogeneous mixture of the polymer and the radiopacifying agent from an appropriate solvent.
- the method of imparting radiopaque characteristics of this invention has a much wider range of structures and applications than the heavy metal sal previously mentioned. The latter are essentially only useful with carbonyl-containing monomers and polymers, while the mor hydrophobic organobismuth and related compounds are soluble i a much wider range of monomers and polymers.
- Useful polymers and mixtures of polymers include those derived from styrene, vinyl halides, alkenes, (e.g., polypropylene), dienes vinylpyridines, those derived from, acrylonitrile, vinyl acetate, acrylates and the like.
- the organometallic compound can also be mixed, or incorporated into condensation polymers. They include linear and cross-linked types formed from dicarboxylic acids and dio or triols.
- polyesters include polyethylene terephthalate, poly (isophthalic acid-co-maleic anhydride), poly (lauric acid-co-glycerol) , an the cross-linked resin poly (phthalic anhydride-co-glycerol) (glyptal) •
- the polyester composite fibers of this invention are especially of interest for making fabrics for clothing to be worn by workers exposed to potentially harmful levels of radiation, such as radiologists and x-ray technicians.
- the heavy metal containing organic compound should b present in an amount sufficient to impart a desired radiopaci to the polymer.
- the relative amounts of the components of composites of this invention depend largely upon the speci heavy metal containing organic compound utilized, the speci polymer or mixture of polymers, the dimensions of the final product and the amount of radiopacity to be imparted to the polymer.
- the heavy metals of the present invention are homogeneously distributed in the pol at the molecular level to form optically lucent radiopaque materials.
- the hydrophobic nature of the heavy metal comp renders them virtually nonleachable from the resin into an aqueous environment to which the composites of this invent may be exposed.
- Non-leachability into many other solvents be achieved by incorporating a polymerizable radiopacifyin agent into the polymer backbone, either by addition polymerization or by condensation polymerization.
- the present invention also contemplates the addit of cross-linking agents. This will provide even greater resistance to leaching of the heavy metal compound from th polymer.
- Suitable representative examples of cross-linkin agents include tetraethylene glycol dimethacrylate (TEG) , divinylbenzene, bisphenol-A-glycidyl methacrylate (BisGMA) the like.
- TEG tetraethylene glycol dimethacrylate
- divinylbenzene divinylbenzene
- bisphenol-A-glycidyl methacrylate bisphenol-A-glycidyl methacrylate
- the linear radiopaque polymeric materials have molecular weights generally ranging from 10,000 to about
- the methods for preparing the homogene radiopaque polymers of the present invention include: a) polymerization at high temperatures; b) room temperature polymerization; c) suspension or emulsion polymerization; d) solvent casting; and e) compounding followed by melt processi Bulk polymerization involves dissolving the heavy metal compound in the monomer(s) and polymerizing in the " presence of an initiator like benzoyl peroxide, azobisisobutyronitrile (AIBN), etc.
- an initiator like benzoyl peroxide, azobisisobutyronitrile (AIBN), etc.
- the heavy metal compound and an initiator are dissolved in the monomer, such as, for example, styrene, and bulk polymerized at elevated temperatures.
- the monomer such as, for example, styrene
- This high temperature bulk method is especiall adaptable for industrial uses.
- the heavy metal organic compounds can be dissolved in styrene and polymerized with AI at the desired temperature.
- Room temperature polymerization can be utilized in this invention since, unlike the bismuth salts previously use to impart radiopacity, the radiopacifying organometallic compounds of this invention do not interfere with the room temperature polymerizations in which a peroxide initiator is
- th 7 homogeneous organometallic-polymer composites may be formed b g film casting methods and solvent evaporation.
- Incorporation Q triphenyl bismuth, for instance, in poly(methyl methacrylate) 0 to form films or transparent radiopaque shields can be 036 I O
- Radiopaque polyesters of the present invention may prepared by dissolving the heavy metal organic compound in polyol, such as, for example, ethylene glycol. The dissolv organometallic compound is then mixed with a dicarboxylic a such as terephthalic acid or phthalic anhydride, and polymerized at elevated temperatures in the presence of a k catalyst.
- a dicarboxylic a such as terephthalic acid or phthalic anhydride
- radiopaque heavy meta compound polymer composites have a wide variety of applicat especially in the dental and medical field.
- radiopaque polymers may be employed in resin systems having levels of cross-linking which, for purposes of the present invention, range from 0 to about 5 percent, and denser more rigid structures having a higher degree of cross-linking ranging from more than 5 to about 15 percent.
- Such systems include "self-curing 11 type resins which react at ambient temperatures of between 25 and 30"C, and systems which cure elevated temperatures with the application of heat.
- the heavy metal-polymer composite would be ground to a fine powder and used as a ' component of a two-part system. More specifically, in the two-part system the composition is furnished in two separate containers.
- the first container would comprise a powder containing a mixture of the radiopaque polymer complex previously described, fillers and an initiator, such as benzo peroxide or AIBN.
- the second container comprises a liquid containing methyl methacrylate monomer, an amine acceleratorator a a cross-linking agent such as ethylene glycol dimethacrylate.
- radiopaque polymer complex When the solutions are mixed, or when in the absence of amine accelerator they are exposed to a strong visible light, the radiopaque polymer complex will swell in the methyl methacrylate monomer and polymerize into a solid homogeneous polymeric mass.
- Applications for the radiopaque polymer composites having low levels of cross-linking include removable dental devices like dentures, bite splints, night guards, orthodontic space maintainers, maxillofacial devices and other nonfixed devices where there is a risk of accidental impaction into the respiratory or digestive tracts.
- radiopaque polymer composites having low levels of cross-linking can also be formulated into bone cements for bonding implanted devices to bone tissues so as to permit monitoring by noninvasive methods
- the second category for biomedical resins include highly cross-linked structures where radiopacity is also a desirable property. They include fixed structures like restorative resins, veneering facings for dental crowns and
- the radiopaque polymer composites may be used with all body implants, prosthetic devices and appliances w are presently used with radiolucent plastics, such as, for example, catheters, bone implants, heart valves or arteries
- Industrial applications for the radiopaque composi of the present invention include x-ray and other radiation shielding devices.
- the transparent radiopaque polymers which are also opaque to U/V radiation, can be us in such areas as aircraft windows and cabins for shielding pilots and astronauts from high energy ⁇ /V and x-radiation found at high altitudes.
- Transparent shielding devices mad sheets of radiopaque plastics for workers exposed to x-rays other forms of potentially harmful radiation are also inten utilities.
- the radiopaque polyester fibers are especially useful in textiles and fabrics for making specialized radiopaque garments to be worn by workers exposed to radia in the job place.
- the radiopaque polymers can be incorporated into any plastic device which requires detect by x-rays.
- the composites of this invention ca be incorporated into plastic firearms to ensure detection by airport security x-ray devices.
- the following specific examples demonstrate the radiopaque polymers and resin compositions, and are representative of the various methods for producing them. However, it is to be understood that these examples are for illustrative purposes only and do not purport to be wholly definitive as to conditions and scope.
- the radiopaque polymers of Examples I-VII were teste to develop data on the possible presence of free triphenylbismuth and the effects of dissolved triphenyl bismu on the glass transition temperature of poly(methyl methylacrylate) by differential scanning calorimetry using a Perkin-Elmer DSC-4 instrument. Scans were run from 50 to 150 with a scan rate of 20°C per minute. A sample of poly(methyl methylacrylate) containing no triphenylbismuth was used as a control for comparison purposes. The results of the DSC 036 analyses are also reported in Table A.
- the radiopacity of the composites of EXAMPLES I-VI was tested as follows: Samples of EXAMPLES I-VII were cut cylindrical pellets of 1 mm and 2 mm thickness. The pellet were polished and placed on a Kodak X-ray film along with a aluminum stepwedge with 1mm steps. The pellets were place inches below the cathode ray tube of an X-ray apparatus an VA* ⁇ exposed to 90 kv 6 nja-s X-rays. Using a microfilm densitom the X-ray absorption of the pellets was then compared with of the aluminum stepwedge.
- Room temperature polymerization in accordance with this invention was performed by dissolving the organometallic compound in the monomer, followed by addition of an initiator and an amine accelerator to form the polymer-organometallic composite.
- the composite of EXAMPLE VIII was prepared according to the following procedure: in a test tube 0.25 grams of triphenylbismuth was dissolved in 0.9 grams of methyl methacrylate to form a clear, homogeneous and transparent solution. Benzoylperoxide, an initiator, was the added to the mixture in an amount of .025 grams or 2.5 weight percent based on the monomer.
- the films formed by this method were transparent, clear and homogeneous. IR spectra of the samples of Examples IX and X show no trace of solvent (THF) left in the film.
- the solvent casting procedure may be used to incorporate organometallic compounds into many other polymer The choice of solvents is dependent on the solubility of the polymers and organometallic compounds in the solvents. For example, an appropriate solvent for incorporating triphenylbismuth into polyacrylonitrile by solvent casting i dimethyl formamide (at 70°C), and for preparing polyethylene-triphenylbismuth composites hexane is an appropriate solvent.
- Radiopaque characteristics may also be imparted to polymers according to this invention by compounding polymer a an organometallic compound followed by melt processing to incorporate heavy metal organometallic compounds into polymers.
- the composites of EXAMPLES XI-XIV were prepared by first mixing (compounding) the triphenylbismuth into isotacti polypropylene and then transferring the mixture to a test tube. The mixture is sealed and the test tube is evacuated. , The mixture is heated above its melting point and kept at tha temperature for a few hours to give a homogeneous, clear and transparent mixture. The mixture on cooling becomes opaque, is pure isotactic polypropylene.
- the weight percent of triphenylbismuth in isotactic polypropylene for EXAMPLES XI-X are shown in TABLE B.
- the isotactic polypropylene-triphenylbismuth samples of EXAMPLES XI-XIV were cut in cylindrical pellets of 1 mm an 2 mm thickness.
- the radiopacity of the samples was measured the same way as described above in regards to EXAMPLES I-VII this invention. It was found that 35 percent by weight triphenyl bismuth was required in a 2mm pellet to provide th same radiopacity as a 2mm pellet of aluminum.
- the thermal properties of the samples of EXAMPLES XI-XIV were tested using the procedures described above in regard to EXAMPLES I-VII.
- the control in this case is pure isotactic polypropylene.
- the results are also shown in TABL TABLE B
- Diphenyl p-styryl bismuth synthesized according t known procedures, was copolymerized with methyl methacrylat bulk with AIBN at 65*C to give a transparent, hard and clea copolymer. Because the monomer-containing heavy metal is p of the backbone of the product, it improves the thermal and mechanical properties of polymers in comparison to material containing heavy metal components as additives only. Its permanent, chemical incorporation into the polymer structur prevents the leaching out of the heavy metal X-ray contrast agent in any kind of solvent ,
- copoly ers were formed using the same procedu given for EXAMPLE XV to " yield poly(methylmethacrylate-co- diphenyl p-styryl bismuth) with different weight percent (or molar ratio) of heavy metal monomer. These copolymers were c in cylindrical pellets of 1mm and 2mm thickness. The radiopacities of the pellets, were measured the same way as mentioned above in regard to Part C Examples I-VII of this invention. It was found that for this copolymer a 2mm thick pellet containing 26 wt% of the bismuth-containing monomer ga the same radiopacity ⁇ 2 mm thick aluminum.
- the Tg of his copolymer was 110*C, close to that of pure poly(methylmethacr late) , a considerable improvement of the Tg of 85 * C (Table A, Example VI) for a composite of poly (methyl methacrylate) and fawe triphenylbismuth.
- the organometallic radiopacifying compounds includedin the radiopacifying monomers of this invention do not interfer with room cured polymerization procedures utilizing amine accelerators.
- EXAMPLE XVI was prepared by the room temperatu polymerization of methyl methacrylate which contained 30 wei 036 «
- the copolymer formed by this method has the same transparen homogeneity, and mechanical and thermal properties as that formed in EXAMPLE XV of this invention.
Landscapes
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- General Engineering & Computer Science (AREA)
- High Energy & Nuclear Physics (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24342688A | 1988-09-12 | 1988-09-12 | |
| US243426 | 1988-09-12 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP0387348A1 true EP0387348A1 (fr) | 1990-09-19 |
| EP0387348A4 EP0387348A4 (en) | 1992-07-08 |
Family
ID=22918741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP19890911685 Withdrawn EP0387348A4 (en) | 1988-09-12 | 1989-09-12 | Homogeneous radiopaque polymer-organobismuth composites |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP0387348A4 (fr) |
| WO (1) | WO1990003036A1 (fr) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1037788C (zh) * | 1992-12-19 | 1998-03-18 | 天津纺织工学院 | 中子和γ射线屏蔽纤维的制造方法 |
| JP3668983B2 (ja) * | 1993-08-23 | 2005-07-06 | 日産化学工業株式会社 | トリス(置換フェニル)ビスマス誘導体 |
| US5939045A (en) * | 1994-12-22 | 1999-08-17 | Nissan Chemical Industries, Ltd. | Organic bismuth derivatives for X-ray imaging |
| FR2755440B1 (fr) * | 1996-11-07 | 1999-01-15 | Tuffet Sophie | Procede de conservation de longue duree de molecules d'adn et conditionnement pour sa mise en oeuvre |
| NZ507970A (en) * | 1998-05-06 | 2003-09-26 | Sophie Tuffet | Method for prolonged storage of DNA molecules and packaging implementing said method |
| DE10004832A1 (de) * | 2000-01-31 | 2001-08-16 | Ethicon Gmbh | Flächiges Implantat mit röntgensichtbaren Elementen |
| US8088158B2 (en) | 2002-12-20 | 2012-01-03 | Boston Scientific Scimed, Inc. | Radiopaque ePTFE medical devices |
| WO2006026725A2 (fr) | 2004-08-31 | 2006-03-09 | C.R. Bard, Inc. | Greffe en polytetrafluorethylene (ptfe) auto-etanche a resistance au tortillement |
| WO2007001472A2 (fr) | 2005-06-17 | 2007-01-04 | C. R. Bard, Inc. | Greffon vasculaire avec une résistance au pliage après le clampage |
| EP1945138A4 (fr) | 2005-11-09 | 2010-02-10 | Bard Inc C R | Greffons et stents-greffons presentant un marqueur radio-opaque |
| DE202010003032U1 (de) * | 2010-02-17 | 2011-08-12 | Ernst Mühlbauer Gmbh & Co. Kg | Infiltrationslösung zur Behandlung einer Zahnschmelzläsion |
| US10026513B2 (en) * | 2014-06-02 | 2018-07-17 | Turner Innovations, Llc. | Radiation shielding and processes for producing and using the same |
| WO2018093566A1 (fr) * | 2016-11-16 | 2018-05-24 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Particules pouvant être imagées, procédés de fabrication et procédés d'utilisation de celles-ci |
| JP7521524B2 (ja) * | 2019-03-28 | 2024-07-24 | 三菱瓦斯化学株式会社 | 光学材料用重合性組成物 |
| JP2022128912A (ja) * | 2021-02-24 | 2022-09-05 | 三菱瓦斯化学株式会社 | 重合性組成物及びそれを重合硬化してなる樹脂 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2833741A (en) * | 1956-03-29 | 1958-05-06 | H D Justi & Son Inc | Method of polymerizing acrylate esters in the presence of an organo-metallic inhibitor |
| US3609372A (en) * | 1963-06-04 | 1971-09-28 | Marxen Friedrich | Shaped polymeric shield against neutron and gamma radiation |
| US3577346A (en) * | 1968-11-14 | 1971-05-04 | Minnesota Mining & Mfg | Insulated electrical conductors having corona resistant polymeric insulation containing organo metallic compounds |
-
1989
- 1989-09-12 EP EP19890911685 patent/EP0387348A4/en not_active Withdrawn
- 1989-09-12 WO PCT/US1989/003966 patent/WO1990003036A1/fr not_active Ceased
Non-Patent Citations (2)
| Title |
|---|
| No further relevant documents have been disclosed * |
| See also references of WO9003036A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO1990003036A1 (fr) | 1990-03-22 |
| EP0387348A4 (en) | 1992-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5256334A (en) | Homogeneous radiopaque polymer-organobismuth composites | |
| US4866132A (en) | Novel radiopaque barium polymer complexes, compositions of matter and articles prepared therefrom | |
| US5024232A (en) | Novel radiopaque heavy metal polymer complexes, compositions of matter and articles prepared therefrom | |
| EP0387348A1 (fr) | Composites de polymere-organobismuth homogenes et radio-opaques | |
| US4882392A (en) | Novel radiopaque heavy metal polymer complexes, compositions of matter and articles prepared therefrom | |
| EP0330346B1 (fr) | Ciment osseux | |
| KR940006106B1 (ko) | 골 시멘트 | |
| CA1263792A (fr) | Materiau de refection dentaire | |
| US4861808A (en) | Glass/poly (carboxylic acid) cement compositions | |
| US5780668A (en) | X-ray opaque dental materials | |
| US3860556A (en) | Low water absorption dental restorative | |
| DE3844619A1 (de) | Verwendung von perfluoroalkylgruppen aufweisenden (meth-)acrylsaeureestern in der dentaltechnik | |
| DE19506222A1 (de) | Verwendung von polymerisierbaren Verbindungen | |
| EP0684222B1 (fr) | (Méth)acrylates monomères et compositions de prothèses dentaires préparées de ceux-ci | |
| Rawls et al. | Cytotoxicity evaluation of a new radiopaque resin additive—triphenyl bismuth | |
| Davy et al. | Radio-opaque denture base: a new acrylic co-polymer | |
| Davy et al. | Iodinated methacrylate copolymers as X-ray opaque denture base acrylics | |
| EP0710475B1 (fr) | Systèmes de résines à indice de réfraction élevé et/ou radio-opacité | |
| US20020143108A1 (en) | Polymerizable compounds and compositions | |
| Delaviz et al. | Homogeneous radiopaque polymers with organobismuth compounds | |
| EP0436382B1 (fr) | Matériau dentaire contenant un additif anti-affaissement | |
| US4831066A (en) | Dental compositions comprising oligomer of hexahydrophtalic anhydride, glycidylmethacrylate and 2-hydroxyethyl-methacrylate | |
| Ignatious et al. | X-ray contrast polymers containing miscible organobismuth compounds | |
| Lang et al. | The effect of triphenylbismuth on the radiopacity and performance properties of compression‐and injection‐molded denture resins | |
| GB2064550A (en) | Radio-opaque dental restorative compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19900510 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 19920515 |
|
| AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
| 17Q | First examination report despatched |
Effective date: 19940225 |
|
| GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 19960326 |